+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

2019 Oral Mucositis Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4768103
  • Report
  • April 2019
  • Region: Global
  • 192 pages
  • VPA Research
1 of 3

FEATURED COMPANIES

  • Amgen Inc
  • Biotec Pharmacon ASA
  • CD Pharma India Pvt Ltd
  • Eisai Co Ltd
  • Galera Therapeutics Inc
  • GlaxoSmithKline Plc
  • MORE
The global clinical trial report- “2019 Oral Mucositis Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Oral Mucositis. It presents in-depth analysis of Oral Mucositis clinical trials across markets and companies. The research work is for providing complete understanding into trends in Oral Mucositis.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Oral Mucositis clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Oral Mucositis

The research work is prepared through extensive and continuous research on Oral Mucositis trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Oral Mucositis patients are identified
  • The report includes panorama of Oral Mucositis clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Oral Mucositis clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Amgen Inc
  • Biotec Pharmacon ASA
  • CD Pharma India Pvt Ltd
  • Eisai Co Ltd
  • Galera Therapeutics Inc
  • GlaxoSmithKline Plc
  • MORE
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Oral Mucositis Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Oral Mucositis Clinical Trials by Region
2.2.2 Average Enrollment of Oral Mucositis Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Oral Mucositis Treatment, 2019

3. Region wise Oral Mucositis Clinical Trials
3.1 Asia Pacific Oral Mucositis Clinical Trials by Country
3.2 Europe Oral Mucositis Clinical Trials by Country
3.3 North America Oral Mucositis Clinical Trials by Country
3.4 Middle East and Africa Oral Mucositis Clinical Trials by Country
3.5 South and Central America Oral Mucositis Clinical Trials by Country

4. Oral Mucositis Clinical Trial Trends
4.1 Start Year wise Oral Mucositis Clinical Trials
4.2 Phase wise Oral Mucositis Clinical Trials
4.3 Trial Status wise Oral Mucositis Clinical Trials
4.4 Trial Type wise Oral Mucositis Clinical Trials

5. Oral Mucositis Average Enrollment Trends
5.1 Average Enrollment in Oral Mucositis Trials by Year
5.2 Average Enrollment in Oral Mucositis Trials by Phase
5.3 Average Enrollment in Oral Mucositis Trials by Status
5.4 Average Enrollment in Oral Mucositis Trials by Type of Trial

6. Companies Participating in Oral Mucositis Clinical Trials
6.1 Oral Mucositis Trials by Sponsor Type
6.2 Oral Mucositis Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Oral Mucositis Trials- Phase 1
7.2 Oral Mucositis Trials- Phase 2
7.3 Oral Mucositis Trials- Phase 3
7.4 Oral Mucositis Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Oral Mucositis Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Oral Mucositis Clinical Trials and Enrolment
Figure 5: Europe - Country wise Oral Mucositis Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Oral Mucositis Clinical Trials and Enrolment
Figure 7: North America - Country wise Oral Mucositis Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Oral Mucositis Clinical Trials and Enrolment
Figure 9: Oral Mucositis Clinical Trials by Phase
Figure 10: Oral Mucositis Clinical Trials by Trial Status
Figure 11: Oral Mucositis Clinical Trials by Type
Figure 12: Oral Mucositis Clinical Trials by Sponsor Type
Figure 13: Oral Mucositis Clinical Trials by Leading Sponsors
Figure 14: Oral Mucositis Average Enrollment by Phase
Figure 15: Oral Mucositis Average Enrollment by Trial Status
Figure 16: Oral Mucositis Average Enrollment by Type
Figure 17: Oral Mucositis- Average Enrolment by Type of Sponsors
Figure 18: Oral Mucositis- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Oral Mucositis Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Oral Mucositis Clinical Trials and Enrolment
Table 5: Europe - Country wise Oral Mucositis Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Oral Mucositis Clinical Trials and Enrolment
Table 7: North America - Country wise Oral Mucositis Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Oral Mucositis Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Oral Mucositis Average Enrollment by Phase
Table 15: Oral Mucositis Average Enrollment by Trial Status
Table 16: Oral Mucositis Average Enrollment by Type
Table 17: Oral Mucositis- Average Enrolment by Type of Sponsors
Table 18: Oral Mucositis- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Amgen Inc
  • Biotec Pharmacon ASA
  • CD Pharma India Pvt Ltd
  • Eisai Co Ltd
  • Galera Therapeutics Inc
  • GlaxoSmithKline Plc
  • Jazz Pharmaceuticals Plc
  • MallInckrodt Plc
  • Novartis AG
  • Swedish Orphan Biovitrum AB
Note: Product cover images may vary from those shown
Adroll
adroll